We have collected information about Nanoparticle Drug Delivery System For Restenosis for you. Follow the links to find out details on Nanoparticle Drug Delivery System For Restenosis.
https://www.sciencedirect.com/science/article/abs/pii/S0169409X96004838
In this review we discuss the therapeutic potential of nanoparticles as a drug delivery system for restenosis. Nanoparticles, for the purpose of this review, are 30–500 nm diameter polymeric spherical particles. Nanoparticles possess several advantages as a carrier system for the intra-arterial localization of therapeutic agents.Author: Vinod D Labhasetwar, Cunxian Song, Robert J. Levy
https://www.sciencedirect.com/science/article/pii/S0169409X96004838
Advantages of nanoparticles as a drug carrier in restenosis Nanoparticles, composed of polymeric material with an entrapped therapeutic agent attached or adsorbed, possess several properties as a drug deliv- ery system which are advantageous for intra-arterial localization of therapeutic agent(s).Author: Vinod D Labhasetwar, Cunxian Song, Robert J. Levy
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249419/
For example, localized delivery of drug-bearing nanoparticles to sites of vascular restenosis may be useful for providing sustained drug release at specific sites on …Author: Rajesh Singh, James W. Lillard, James W. Lillard
http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1381-6128&volume=19&issue=35&spage=6330
Keywords:Restenosis, nanoparticle, drug delivery, layered double hydroxide. Abstract:Restenosis, the re-narrowing of a blood vessel after removal of atherosclerotic plaque, is a major limitation of surgical treatments for atherosclerosis. Various attempts to prevent or treat restenosis by pharmacological or mechanical approaches have had limited success in clinical trials.
https://www.thno.org/v04p0175.htm
Of the drugs investigated for restenosis prevention and treatment, only paclitaxel and sirolimus have been successfully administered through nanoparticle-based delivery systems and only in …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102631/
A nanoparticle based approach is ideal for the treatment of restenosis since targeted delivery of nanoparticles is feasible and much lower concentrations of the active drug …Author: Garry McDowell, Mark Slevin, Mark Slevin, Jerzy Krupinski
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527668/
The aims for nanoparticle entrapment of drugs are either enhanced delivery to, or uptake by, target cells and/or a reduction in the toxicity of the free drug to non-target organs. Both situations will result in an increase of therapeutic index, the margin between the doses resulting in a therapeutic efficacy (eg,...Author: Wim H De Jong, Paul Ja Borm
https://www.sciencedirect.com/science/article/pii/B9780128136898000021
Nanoparticle drug delivery systems (NPDDS) achieve superior entry for the particles inside the body, as their size permits conveyance by means of intravenous infusion or different courses. Another important use of the NPDDS is in the production of the antibodies …Author: Deepti Sharma, Navneet Sharma, Mallika Pathak, Paban K. Agrawala, Mitra Basu, Himanshu Ojha
https://www.deepdyve.com/lp/elsevier/nanoparticle-drug-delivery-system-for-restenosis-IOytO3iN2q
In recent years, several local drug delivery strategies have been investigated for the prevention of restenosis. In this review we discuss the therapeutic potential of nanoparticles as a drug delivery system for restenosis. Nanoparticles, for the purpose of this review, are 30–500 nm diameter polymeric spherical particles.
Searching for Nanoparticle Drug Delivery System For Restenosis?
You can just click the links above. The data is collected for you.
